Author： Macchia Alejandro
Publisher： Springer Publishing Company
ISSN： 0031-6970
Source： European Journal of Clinical Pharmacology, Vol.64, Iss.6, 2008-06, pp. : 627-634
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Omega-3 fatty acid supplementation appears to reduce 1-year atrial fibrillation (AF) risk
Inpharma, Vol. 1, Iss. 1648, 2008-01 ,pp. :
Access to resources
Recommend
Omega 3 fatty acid supplementation may be beneficial for patients with recurrent self-harm
Inpharma, Vol. 1, Iss. 1584, 2007-01 ,pp. :
Omega-3 fatty acid reduces cytokine levels in COPD
Inpharma, Vol. 1, Iss. 1526, 2006-01 ,pp. :
Valsartan reduces risk of atrial fibrillation in heart failure
Inpharma, Vol. 1, Iss. 1488, 2005-01 ,pp. :
Ximelagatran reduces stroke risk in atrial fibrillation
Inpharma, Vol. 1, Iss. 1387, 2003-01 ,pp. :